Cellectar Biosciences, Inc. · NASDAQ:CLRB
Balyasny Asset Management L.P. reported a 9.99% stake in Cellectar Biosciences, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Balyasny Asset Management L.P. reported a 9.99% stake in Cellectar Biosciences, Inc., 798,382 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 798,382
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 9.99% | 798,382 |
| BAM GP LLC | 9.99% | 798,382 |
| Balyasny Asset Management Holdings LP | 9.99% | 798,382 |
| Dames GP LLC | 9.99% | 798,382 |
| Dmitry Balyasny | 9.99% | 798,382 |
Source
Related
- Cellectar Biosciences, Inc.
- Balyasny Asset Management L.P.
- Cellectar Biosciences, Inc. shareholders
- Schedule 13G · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · Silverarc Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Bleichroeder LP · Aug 13, 2026
- Schedule 13G · Empery Asset Management, LP · Aug 4, 2026